Ming Zhai
- Topics
- Epigenetics and DNA Methylation (3 papers)Atherosclerosis and Cardiovascular Diseases (3 papers)Immune cells in cancer (3 papers)
- Cited by
- ImmunologyHematologyNeurology
- Partner nations
- ChinaUnited States
In The Last Decade
Ming Zhai
18 papers receiving 274 citations
Peers
Comparison fields: 5 of 58
- Molecular Biology 105
- Immunology 72
- Oncology 55
- Cardiology and Cardiovascular Medicine 50
- Surgery 43
Countries citing papers authored by Ming Zhai
This map shows the geographic impact of Ming Zhai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ming Zhai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ming Zhai more than expected).
Fields of papers citing papers by Ming Zhai
This network shows the impact of papers produced by Ming Zhai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ming Zhai. The network helps show where Ming Zhai may publish in the future.
Co-authorship network of co-authors of Ming Zhai
This figure shows the co-authorship network connecting the top 25 collaborators of Ming Zhai. A scholar is included among the top collaborators of Ming Zhai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ming Zhai. Ming Zhai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 2 | |
| 4 | 46 | |
| 5 | 6 | |
| 6 | 5 | |
| 7 | 16 | |
| 8 | 16 | |
| 9 | 0 | |
| 10 | 40 | |
| 11 | 8 | |
| 12 | 13 | |
| 13 | 21 | |
| 14 | 0 | |
| 15 | 22 | |
| 16 | 8 | |
| 17 | 33 | |
| 18 | 5 | |
| 19 | 15 | |
| 20 | [A multi-center clinical trial of recombinant human thrombopoietin in chronic refractory idiopathic thrombocytopenic purpura]. | 20 |
About Ming Zhai
Ming Zhai is a scholar working on Immunology, Hematology and Cancer Research, having authored 22 papers that have together received 278 indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (3 papers), Atherosclerosis and Cardiovascular Diseases (3 papers) and Immune cells in cancer (3 papers). The work is most often cited by research in Immunology (72 citations), Hematology (36 citations) and Neurology (20 citations). Ming Zhai has collaborated with scholars based in China and United States. Frequent co-authors include Wenhui Peng, Weixia Jian, Yanxi Zeng, Wenxin Kou, Hui He, Jianhui Zhuang, Hong‐Hao Zhou, Peipei Luan, Mark W. Feinberg and Yu Zhang. Their work appears in journals such as Journal of Clinical Investigation, Nature Communications and Circulation Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.